Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.41 |
| ▸ | FDPS | P14324 | 9/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8026010 | 0.90 | TSHR (0.36) | GGPS1SMPD1FDPSTSHRTHRB | |
| SCHEMBL14224343 | 0.85 | TSHR (0.33) | FDPSTSHR | |
| SCHEMBL24496713 | 0.81 | GGPS1 (0.39) | GGPS1SMPD1FDPSTSHRTHRB | |
| SCHEMBL24496681 | 0.81 | GGPS1 (0.39) | GGPS1SMPD1FDPSTSHRTHRB | |
| SCHEMBL24496700 | 0.81 | GGPS1 (0.39) | GGPS1SMPD1FDPSTSHRTHRB | |
| SCHEMBL3628284 | 0.80 | TSHR (0.44) | GGPS1SMPD1FDPSTSHRTHRB | |
| SCHEMBL11514263 | 0.80 | TSHR (0.39) | FDPSTSHR | |
| SCHEMBL8740256 | 0.80 | GGPS1 (0.41) | GGPS1SMPD1FDPSTSHRTHRB | |
| SCHEMBL3574443 | 0.80 | GGPS1 (0.41) | GGPS1SMPD1FDPSTSHRTHRB | |
| SCHEMBL8062566 | 0.79 | TSHR (0.44) | GGPS1SMPD1FDPSTSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10361381-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10361381-B2 | Organic electroluminescent materials and devices | NR1D2, NR1D1, NR1H2 | GGPS1 72/4885SMPD1 4443/4885FDPS 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.